Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Atomoxetine and Placebo in Children With ADHD and/or Reading Disorder
This study has been completed.
Study NCT00191906 Information provided by Eli Lilly and Company
First Received: September 12, 2005 Last Updated: September 19, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Reading Disorder
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
Disease
Dyslexia
Hyperkinesis
More general conditions related to this trial
Attention Deficit and Disruptive Behavior Disorders
Communication Disorders
Dyskinesias
Language Disorders
Learning Disorders
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
Atomoxetine Hydrochloride
placebo
Additional drug interventions recognized in this trial
Atomoxetine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eli Lilly and Company
Back to top of Main Content
